These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 8247385

  • 1. Functional alterations in dopamine systems assessed using drug discrimination procedures.
    Cory-Slechta DA, Widzowski DV, Pokora MJ.
    Neurotoxicology; 1993; 14(2-3):105-14. PubMed ID: 8247385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.
    Cory-Slechta DA, Pokora MJ, Fox RA, O'Mara DJ.
    Neurotoxicology; 1996; 17(2):445-57. PubMed ID: 8856740
    [Abstract] [Full Text] [Related]

  • 4. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA, Pokora MJ, Widzowski DV.
    Brain Res; 1992 Dec 11; 598(1-2):162-72. PubMed ID: 1362517
    [Abstract] [Full Text] [Related]

  • 5. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul 11; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 6. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW, Bergman J.
    J Pharmacol Exp Ther; 1998 Jun 11; 285(3):1163-74. PubMed ID: 9618419
    [Abstract] [Full Text] [Related]

  • 7. Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment.
    Zuch CL, O'Mara DJ, Cory-Slechta DA.
    Toxicol Appl Pharmacol; 1998 May 11; 150(1):174-85. PubMed ID: 9630467
    [Abstract] [Full Text] [Related]

  • 8. Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels.
    Zapata A, Shippenberg TS.
    Neuropharmacology; 2005 Jan 11; 48(1):43-50. PubMed ID: 15617726
    [Abstract] [Full Text] [Related]

  • 9. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 11; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 10. Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.
    Lawler CP, Gilmore JH, Watts VJ, Walker QD, Southerland SB, Cook LL, Mathis CA, Mailman RB.
    Synapse; 1995 Dec 11; 21(4):299-311. PubMed ID: 8869160
    [Abstract] [Full Text] [Related]

  • 11. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.
    Brain Res; 2008 Mar 10; 1198():44-54. PubMed ID: 18261716
    [Abstract] [Full Text] [Related]

  • 12. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T.
    Mol Pharmacol; 1996 Nov 10; 50(5):1073-9. PubMed ID: 8913337
    [Abstract] [Full Text] [Related]

  • 13. Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
    Bauter MR, Brockel BJ, Pankevich DE, Virgolini MB, Cory-Slechta DA.
    Neurotoxicology; 2003 Mar 10; 24(2):227-43. PubMed ID: 12606295
    [Abstract] [Full Text] [Related]

  • 14. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T.
    Drug Metab Dispos; 1997 Jun 10; 25(6):675-84. PubMed ID: 9193868
    [Abstract] [Full Text] [Related]

  • 15. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T, Seeman P, Kuroiwa M, Nishi A.
    Eur J Neurosci; 2008 May 10; 27(10):2551-7. PubMed ID: 18489579
    [Abstract] [Full Text] [Related]

  • 16. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J, Vargas G, Morales-Medina JC, Rivera G, De La Cruz F, Zamudio S, Flores G.
    Synapse; 2008 Jan 10; 62(1):40-9. PubMed ID: 17957737
    [Abstract] [Full Text] [Related]

  • 17. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dopamine D1 and D2 receptors regulate extracellular lactate and glucose concentrations in the nucleus accumbens.
    Uehara T, Sumiyoshi T, Itoh H, Kurachi M.
    Brain Res; 2007 Feb 16; 1133(1):193-9. PubMed ID: 17184754
    [Abstract] [Full Text] [Related]

  • 20. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M, Przegaliński E.
    Pol J Pharmacol; 1997 Feb 16; 49(1):21-30. PubMed ID: 9431548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.